Moderna CEO Defends Pricing Plans for Covid-19 Shot

[ad_1] Stéphane Bancel said investors funded the mRNA vaccine platform. [ad_2] Source link

Seagen’s Cancer Therapy Is Making It a Takeover Target

[ad_1] Health Novel cancer agents could shore up aging pharmaceutical portfolios for big drugmakers [ad_2] Source link

WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 Billion

[ad_1] WSJ News Exclusive Deals Potential deal would help the drug company add to its lineup of cancer treatments [ad_2] Source link

Collecting Pharma’s Scraps Can Pay Off for This Biotech

[ad_1] Markets Heard on the Street Roivant has built a unique model that allows it to benefit from big pharma’s need to reduce R&D spending [ad_2] Source link

Drugmakers Raise Prices on Nearly 1,000 Medicines but Show Restraint

[ad_1] Health List prices climb by 5.6% on average as new federal law aims to lower drug costs [ad_2] Source link

Pfizer Bids Adieu to Covid Boom Years

[ad_1] Markets Heard on the Street Financial bonanza from Covid-19 is fading, putting pressure on management to deliver new avenues of growth [ad_2] Source link

Pfizer Expects Drop in Revenue as Covid Vaccine Demand Wanes

[ad_1] Business Health Care Health Drugmaker says in earnings report it anticipates return in growth for Covid-products in 2024 [ad_2] Source link

Amazon, Apple, Alphabet Headline Another Busy Earnings Week

[ad_1] Business Earnings Ford, McDonald’s, Pfizer join tech titans in providing quarterly updates, as layoffs spread and growth slows [ad_2] Source link

A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them.

[ad_1] Pharmaceutical companies could try to blunt the limits on future price increases. [ad_2] Source link

China’s Shortage of Antivirals Puts Vulnerable People at Risk

[ad_1] China is struggling with shortages of lifesaving antivirals more than a month after its government made an abrupt U-turn on its zero-Covid policies. [ad_2] Source link